You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Oct. 26, 2016 /PRNewswire/ -- Astellas USA Foundation has named Moyra Knight as president, transitioning from Jeffrey A. Winton, outgoing Astellas USA Foundation president. Winton led the Foundation since 2014 and he will continue in his role as senior vice president, Corporate Affairs at Astellas. Knight has served as an Astellas USA Foundation advisory committee member since 2014.
"Astellas USA Foundation is committed to supporting programs and partners that cultivate healthy, educated and resilient communities," said Winton. "Moyra's more than 20 years of experience in volunteerism, public-private partnerships, CSR and philanthropy will continue to build upon the Foundation's mission."
Astellas USA Foundation, www.astellasusafoundation.org, is focused on three philanthropic pillars:
"Astellas USA Foundation enriches lives throughout the Americas, often during a time of greatest need," said Knight. "We will continue to advance Astellas USA Foundation's mission by strengthening communities and helping individuals to thrive. I am honored to be selected for this new role."
Robin Andrews will continue to lead programming in the Foundation's core focus areas, including health and well-being, STEM education and disaster response, and will now report to Knight.
About Astellas USA Foundation
Astellas USA Foundation is a tax-exempt, nonprofit corporate foundation that awards grants to support charitable, scientific, literary and educational programs. Learn more at www.astellasusafoundation.org. You can also follow us on Twitter at @AstellasFDN or Facebook at www.facebook.com/AstellasFoundation.
Photo - http://photos.prnewswire.com/prnh/20161025/432580
SOURCE Astellas USA Foundation
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.